- JP-listed companies
- TORII PHARMACEUTICAL CO., LTD.
- Income statement
TORII PHARMACEUTICAL CO., LTD.【JP:E00934】Income statement
Market cap
P/E ratio
| 2011/03 | 2012/03 | 2013/03 | 2014/03 | 2014/12 | 2015/12 | 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | |
| Revenue | 45,335 | 48,717 | 52,294 | 58,109 | 43,504 | 62,378 | 60,206 | 64,135 | 62,551 | 42,998 | 41,700 | 46,987 | 48,896 | 54,638 | 60,426 |
| Cost of revenue | - | - | - | - | 20,587 | 30,814 | 30,287 | 31,293 | 31,844 | 20,702 | 19,962 | 22,649 | 25,516 | 29,847 | 33,719 |
| Gross profit | - | - | - | - | 22,917 | 31,564 | 29,919 | 32,841 | 30,707 | 22,295 | 21,737 | 24,338 | 23,379 | 24,791 | 26,707 |
| Gross margin (%) | - | - | - | - | |||||||||||
| Operating expenses | - | - | - | - | 18,885 | 26,645 | 26,099 | 26,559 | 25,755 | 20,864 | 16,999 | 19,682 | 17,839 | 19,755 | 19,908 |
| Operating income | - | - | - | - | 4,032 | 4,919 | 3,819 | 6,281 | 4,951 | 1,430 | 4,738 | 4,656 | 5,540 | 5,035 | 6,798 |
| Income before tax | 2,015 | 4,338 | 2,952 | 5,124 | 4,142 | 5,135 | 3,999 | 6,403 | 5,080 | 1,691 | 4,971 | 4,847 | 5,537 | 5,307 | 6,926 |
| Provision for income taxes | - | - | - | - | 1,361 | 1,730 | 1,216 | 1,655 | 1,865 | 10,333 | 729 | 1,392 | 1,778 | 1,473 | 1,682 |
| Net income | 937 | 2,611 | 1,849 | 3,352 | 2,419 | 3,527 | 2,839 | 4,718 | 1,164 | 27,367 | 3,495 | 3,374 | 3,944 | 4,119 | 5,042 |
| Earnings per share | 33.11 | 92.27 | 65.36 | 118.47 | 85.5 | 124.65 | 100.41 | 168.22 | 41.51 | 974.98 | 124.47 | 120.13 | 140.39 | 146.6 | 179.38 |
| Diluted EPS | - | - | - | - | - | - | - | 168.22 | - | - | 124.46 | - | - | - | - |
| Dividend per share | 40 | 40 | 40 | 40 | 40 | 48 | 48 | 48 | 48 | 48 | 48 | 48 | 100 | 120 | 120 |